Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Item No. 27765
![Histone H3K27Me1 (21-44)-GK-biotin (trifluoroacetate salt) (ATKAAR-K(Me1)-SAPATGGVKKPHRYRPG-GK(Biotin), [Lys(Me1)27]-Histone H3 (21-44)-GK(Biotin), Histone H3 (21-44) (Lys27me1))](https://cdn2.caymanchem.com/cdn/productImages/27765.png)
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Histone H3K27Me1 (21-44)-GK-biotin is a peptide fragment of histone H3 that corresponds to amino acid residues 22-45 of the human histone H3.1 and H3.2 sequences. It is monomethylated at lysine 27 and biotinylated via a C-terminal GK linker. Monomethylation of histone H3 at lysine 27 is associated with actively transcribed genes and positively correlates with H3K36 trimethylation.1 Levels of H3K27Me1 are increased in tumor tissue isolated from patients with metastatic hormone-naïve and castration-resistant prostate cancer.2 Histone H3K27Me1 (21-44)-GK-biotin has been used in a high-throughput screen for inhibitors of the histone demethylase jumonji AT-rich interactive domain 1B (JARID1B).3
WARNING This product is not for human or veterinary use.
1. Polycomb-
2. Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Invest. 30(2), 92-97 (2012).
3. Identification of small molecule inhibitors of Jumonji AT-